These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 10393675)

  • 21. Time to reperfusion with direct coronary angioplasty and thrombolytic therapy in acute myocardial infarction.
    Berger PB; Bell MR; Holmes DR; Gersh BJ; Hopfenspirger M; Gibbons R
    Am J Cardiol; 1994 Feb; 73(4):231-6. PubMed ID: 8296752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute myocardial infarction: immediate coronary angioplasty for failure or contra-indications of thrombolytic therapy. Apropos of a series of 100 cases].
    Mossard JM; Arbogast R; Roman S; Baruthio J; Germain P; Roul G; Kraenner C; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1991 Apr; 84(4):469-75. PubMed ID: 1905914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Holmes DR; Bates ER; Kleiman NS; Sadowski Z; Horgan JH; Morris DC; Califf RM; Berger PB; Topol EJ
    J Am Coll Cardiol; 1995 Sep; 26(3):668-74. PubMed ID: 7642857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction.
    Zeymer U; Schröder R; Machnig T; Neuhaus KL
    Am Heart J; 2003 Oct; 146(4):686-91. PubMed ID: 14564324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes.
    Batchelor WB; Granger CB; Kleiman NS; Phillips HR; Ellis SG; Betriu A; Criger DA; Stebbins AL; Topol EJ; Califf RM;
    Am J Cardiol; 2000 Mar; 85(6):692-7. PubMed ID: 12000041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Barbash GI; Roth A; Hod H; Modan M; Miller HI; Rath S; Zahav YH; Keren G; Motro M; Shachar A
    Am J Cardiol; 1990 Sep; 66(5):538-45. PubMed ID: 2118299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.
    Cannon CP; Gibson CM; Lambrew CT; Shoultz DA; Levy D; French WJ; Gore JM; Weaver WD; Rogers WJ; Tiefenbrunn AJ
    JAMA; 2000 Jun; 283(22):2941-7. PubMed ID: 10865271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial.
    Gibson CM; Cannon CP; Greene RM; Sequeira RF; Margorien RD; Leya F; Diver DJ; Baim DS; Braunwald E
    Am J Cardiol; 1997 Jul; 80(1):21-6. PubMed ID: 9205014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Balancing the benefits of primary angioplasty against the benefits of thrombolytic therapy for acute myocardial infarction: the importance of timing.
    Kent DM; Lau J; Selker HP
    Eff Clin Pract; 2001; 4(5):214-20. PubMed ID: 11685979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How long is too long? Association of time delay to successful reperfusion and ventricular function outcome in acute myocardial infarction: the case for thrombolytic therapy before planned angioplasty for acute myocardial infarction.
    Lundergan CF; Reiner JS; Ross AM
    Am Heart J; 2002 Sep; 144(3):456-62. PubMed ID: 12228782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial.
    Holmes DR; Califf RM; Van de Werf F; Berger PB; Bates ER; Simoons ML; White HD; Thompson TD; Topol EJ
    Lancet; 1997 Jan; 349(9045):75-8. PubMed ID: 8996417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.
    Circulation; 1994 Oct; 90(4):1631-7. PubMed ID: 7923645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct angioplasty versus initial thrombolytic therapy for acute myocardial infarction: long-term follow-up and changes in practice pattern.
    Vacek JL; Rosamond TL; Kramer PH; Crouse LJ; Robuck OW; White JL; Beauchamp GD
    Am Heart J; 1992 Dec; 124(6):1411-8. PubMed ID: 1462893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aggressive intervention for myocardial infarction: angioplasty, stents, and intra-aortic balloon pumping.
    Grines CL
    Am J Cardiol; 1996 Aug; 78(3A):29-34. PubMed ID: 8751844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups.
    Gibbons RJ; Holmes DR; Reeder GS; Bailey KR; Hopfenspirger MR; Gersh BJ
    N Engl J Med; 1993 Mar; 328(10):685-91. PubMed ID: 8433727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open design, multicentre, randomized trial of percutaneous transluminal coronary angioplasty versus stenting, with a heparin-coated stent, of totally occluded coronary arteries: rationale, trial design and baseline patient characteristics. Total Occlusion Study of Canada (TOSCA) Investigators.
    Dzavik V; Carere RG; Teo KK; Knudtson ML; Marquis JF; Buller CE
    Can J Cardiol; 1998 Jun; 14(6):825-32. PubMed ID: 9676168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin dosing and outcome in acute coronary syndromes: the GUSTO-IIb experience. Global Use of Strategies to Open Occluded Coronary Arteries.
    Gilchrist IC; Berkowitz SD; Thompson TD; Califf RM; Granger CB
    Am Heart J; 2002 Jul; 144(1):73-80. PubMed ID: 12094191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Pilote L; Califf RM; Sapp S; Miller DP; Mark DB; Weaver WD; Gore JM; Armstrong PW; Ohman EM; Topol EJ
    N Engl J Med; 1995 Aug; 333(9):565-72. PubMed ID: 7623907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial.
    Labinaz M; Kaul P; Harrington RA; Chang WC; Kleiman NS; Simoons ML; Boersma E; Akkerhuis KM; Califf RM; Armstrong PW;
    Can J Cardiol; 2004 Jun; 20(8):773-8. PubMed ID: 15229770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rescue angioplasty during myocardial infarction has a beneficial effect on mortality: a tenable hypothesis.
    Belenkie I; Traboulsi M; Hall CA; Hansen JL; Roth DL; Manyari D; Filipchuck NG; Schnurr LP; Rosenal TW; Smith ER
    Can J Cardiol; 1992 May; 8(4):357-62. PubMed ID: 1617519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.